Inexpensive OCT glaucoma assessment tool can track MS activity
January 16, 2008, Buffalo, NY--New research by neurologists at the University at Buffalo has shown that optical coherence tomography (OCT) also could be used as a surrogate marker of disease status in multiple sclerosis (MS) and to assess the effectiveness of new and current MS treatments.
Read Full Article
Related Articles
- Assessment of macular retinal thickness and volume in normal eyes and highly myopic eyes with third-generation optical coherence tomography also categorized in Ophthalmology
- Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation also categorized in Ophthalmology
- Correlation between microaneurysm closure rate and reduction in macular thickness following laser photocoagulation of diabetic macular edema also categorized in Ophthalmology
- Optical coherence tomography on autologous translocation of choroid and retinal pigment epithelium in age-related macular degeneration also categorized in Ophthalmology
- CardioSpectra gets boost in OCT development from Volcano also published in BioOptics World
- Automatic retinal blood flow calculation using spectral domain optical coherence tomography also categorized in Ophthalmology
- A Comparison of Macular Structure Imaged by Optical Coherence Tomography in Preterm and Full-Term Children also categorized in Ophthalmology
- Optical coherence tomography and disease subtype in multiple sclerosis also mentions University of Alabama
- Michelson Diagnostics Announces Upgraded OCT Product also published in BioOptics World
- Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy also categorized in Ophthalmology
Login to comment.